Neurocrine Biosciences shares owned by Royal London Asset Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Royal London Asset Management
from 13F filings
Historical chart of Royal London Asset Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Royal London Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Royal London Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $6.3M | 46k | 137.67 |
| 2024-03-31 | $6.3M | 46k | 137.92 |
| 2023-12-31 | $4.2M | 32k | 131.76 |
| 2023-09-30 | $3.6M | 32k | 112.52 |
| 2023-06-30 | $2.8M | 30k | 94.27 |
More positions owned by Royal London Asset Management
View all positions for Royal London Asset Management